New hope for rare lung cancer mutations: targeted pill under study
NCT ID NCT06010329
First seen May 01, 2026 · Last updated May 01, 2026 · Updated 1 time
Summary
This study tests a new oral drug, sutetinib maleate, in people with advanced non-small cell lung cancer that has uncommon EGFR mutations. The goal is to see if the drug can shrink tumors or slow cancer growth. About 66 adults with measurable tumors and good organ function will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mission Cancer + Blood - Mission Cancer Foundation
RECRUITINGDes Moines, Iowa, 50309, United States
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
-
Northwell Health
ACTIVE_NOT_RECRUITINGNew Hyde Park, New York, 11042, United States
-
Norton Cancer Institute - Downtown
WITHDRAWNLouisville, Kentucky, 40202, United States
-
Oncology Physicians Network Healthcare
WITHDRAWNGlendale, California, 91203, United States
-
Perlmutter Cancer Center - 34th Street
RECRUITINGNew York, New York, 10016, United States
-
University Cancer & Blood Center (UCBC) - Athens
RECRUITINGAthens, Georgia, 30607, United States
-
University of California San Diego Moores Cancer Center
RECRUITINGLa Jolla, California, 92093, United States
-
University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.